BioSpace News Archive

Portage invests in iOx Therapeutics, an United Kingdom-based cancer immunotherapy company

Portage will invest US$950,000 by subscribing to an unsecured, one-year convertible loan instrument.

March 8, 2018
·
5 min read
Business

Concordia International Corp. Announces Fourth Quarter and Fiscal 2017 Results

2017 revenue of $626 million.

March 8, 2018
·
39 min read
Pharm Country

Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with Parkinson’s and Other Neurodegenerative Diseases

Investors in the round included OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners L.P., Boxer Capital, LLC, Adage Capital Management L.P., and Alexandria Venture Investments.

March 8, 2018
·
4 min read
Business

Seres Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates

Positive SER-287 Phase 1b clinical and microbiome results support further development; Company plans to initiate next clinical trial in mid-2018.

March 8, 2018
·
16 min read
Pharm Country

NHF Launches 2018 Red Tie Campaign to Protect Access to Affordable, Quality Healthcare for People with Bleeding Disorders

NHF marks Bleeding Disorders Awareness Month and its 70th anniversary on March 8 with advocacy event on Capitol Hill

March 8, 2018
·
5 min read
Pharm Country

Onkos Surgical® Announces Major Milestone with First Patient Entered in the Surgical Oncology Research Team (SORT™) Registry

The SORT Registry, sponsored by Onkos Surgical, is the first of its kind, multicenter, platform designed to prospectively collect functional, psychosocial and oncological outcomes.

March 8, 2018
·
3 min read
Business

CosmosID Appoints Arne Materna as Vice President of Product

Dr. Materna’s experience in product and business strategy in the field of metagenomics and infectious disease genomics will fuel the strategic expansion of the product portfolio and the growth of CosmosID.

March 8, 2018
·
2 min read
Business

Zipongo Adds Chief Medical Officer To The Team To Support Company’s Roll Out Of “FoodScripts™"

Dr. Dexter Shurney, MD, MBA, MBH joins company as Chief Medical Officer as Zipongo ramps development of Food as Medicine to tackle chronic disease.

March 8, 2018
·
4 min read
Business

Ocular Therapeutix™ Reports Fourth Quarter and Year End 2017 Financial Results and Business Update

DEXTENZA™ New Drug Application (NDA) resubmission to the U.S. Food and Drug Administration (FDA) remains on track for the first half of 2018

March 8, 2018
·
15 min read
Drug Development

Aptinyx Presents Preclinical and Phase 1 Clinical Data from NYX-2925 at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics

Aptinyx Inc. announced they will present preclinical and early-stage clinical data from studies of the company’s lead product candidate, NYX-2925, at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics, March 7-10, 2018 in Rockville, MD.

March 8, 2018
·
2 min read